Evidence map›Paper›PMID 40093535›Full record

ArticleFrontiers in cellular and infection microbiology2025

Major antigenic differences in

Marcos Mancilla, Adriana Ojeda, Yassef Yuivar, Maritza Grandón, Horst Grothusen, Marcela Oyarzún, Alejandro Bisquertt, Juan A Ugalde, Francisco Fuentes, Pablo Ibarra and 1 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Pathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Nanopore genome sequencing ofFrontiers in genetics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marcos Mancilla *Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile, Puerto Montt, Chile.
Adriana Ojeda *Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile, Puerto Montt, Chile.
Yassef Yuivar *Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile, Puerto Montt, Chile.
Maritza GrandónLaboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile, Puerto Montt, Chile.
Horst GrothusenLaboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile, Puerto Montt, Chile.
Marcela OyarzúnTEKBios Fish Trial Center, Maullín, Chile.
Alejandro BisquerttCodebreaker Bioscience, Providencia, Chile.
Juan A UgaldeCenter for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
Francisco FuentesCenter for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
Pablo IbarraTEKBios Fish Trial Center, Maullín, Chile.
Patricio BustosLaboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile, Puerto Montt, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aeromonas salmonicidaAntigenic VariationAntigens, BacterialFish DiseasesFurunculosisGram-Negative Bacterial InfectionsSalmonAnimalsAquacultureBacterial Outer Membrane ProteinsBacterial ProteinsChileLipopolysaccharidesVirulence FactorsAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsLipopolysaccharidesVirulence FactorsAeromonas salmonicidaantigenfurunculosislipopolysaccharidevaccineVapA

Identifiers

PMID40093535
PMCPMC11906462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.